Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02601313
Title A Phase 2 Multicenter Study Evaluating Subjects With Relapsed/Refractory Mantle Cell Lymphoma (ZUMA-2)
Acronym ZUMA-2
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kite Pharma, Inc.
Age Groups: adult | senior
Covered Countries USA | NLD | FRA | DEU

No variant requirements are available.